Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Eltrombopag for Refractory Severe Aplastic Anemia: Dosing Regimens, Long-Term Follow-up, Clonal Evolution and Somatic Mutation Profiling

Thomas Winkler, MD, James N. Cooper, MD, Danielle M. Townsley, MDMSc, Phillip Scheinberg, MD, Sophia Grasmeder, RN, Colin Wu, PhD, Jennifer Lotter, Marie J Desierto, MS, Ronan Desmond, MD, Matthew J. Olnes, MD PhD, Katherine R Calvo, MD PhD, Neal S. Young, MD, Cynthia E Dunbar, MD

Blood (2017) 130 (Supplement 1): 777.

https://doi.org/10.1182/blood.V130.Suppl_1.777.777

Published: 2017

Journal Articles

Persistent Elevation of Plasma Thrombopoietin Levels in Severe Aplastic Anemia, Even with Hematologic Recovery

Xin Zhao, MD PhD, Xingmin Feng, PhD, Danielle M. Townsley, MD, Thomas Winkler, MD, Ronan Desmond, MD, Matthew J. Olnes, MD PhD, Harshraj Leuva, Bogdan Dumitriu, MD, Cynthia E. Dunbar, MD, Neal S. Young, MD

Blood (2015) 126 (23): 3609.

https://doi.org/10.1182/blood.V126.23.3609.3609

Published: 2015

Journal Articles

Alemtuzumab Is Safe and Associated With High Response Rates In Selected Patients With Myelodysplastic Syndrome

Vishal N. Ranpura, MD, Colin O. Wu, Matthew J. Olnes, MD, PhD, Ankur R. Parikh, DO, Aarthi Shenoy, MD, Barbara Weinstein, RN, Phillip Scheinberg, MD, A. John Barrett, Neal S. Young, MD, Christopher S. Hourigan, MD, PhD, Ronan Desmond, MD

Blood (2013) 122 (21): 593.

https://doi.org/10.1182/blood.V122.21.593.593

Published: 2013

Journal Articles

Ultra-Low Dose IL-2 Safely Expands Regulatory T Cells and CD56 bright NK Cells in Healthy Volunteers: Towards Safer Stem Cell Donors?

Sawa Ito, MD, Minoo Battiwalla, MD, MS, J. Joseph Melenhorst, Ph.D., Mattias Carlsten, MD Ph.D, Angelique Biancotto, PhD, Ena Wang, M.D., Zhi Xie, Ph.D., Pawel Muranski, MD, Matthew J. Olnes, MD, PhD, Kazushi Tanimoto, MD, Paula Schum, R.N., Shira Perl, MD, Howard Dickler, MD, J. Philip McCoy, PhD, Thomas Hughes, Pharm D, Leodayan Bojanowski, DNP, CIP, RN, Nancy F. Hensel, BS, Neal S. Young, MD, A. John Barrett, MD

Blood (2012) 120 (21): 3283.

https://doi.org/10.1182/blood.V120.21.3283.3283

Published: 2012

Journal Articles

Immunosuppressive Treatment for Patients with Myelodysplastic Syndromes: A Review of 358 Patients

Ankur R. Parikh, DO, Yang Yang, Colin O. Wu, PhD, Andrea Poon, Karen G. Smith, Neal S. Young, MD, A. John Barrett, MD, Matthew J. Olnes, MD, PhD

Blood (2011) 118 (21): 1717.

https://doi.org/10.1182/blood.V118.21.1717.1717

Published: 2011

Journal Articles

Eltrombopag Can Stimulate Trilineage Hematopoiesis with Transfusion Independence in Patients with Refractory Severe Aplastic Anemia: Results From a Phase II Trial

Matthew J. Olnes, MD, PhD, Phillip Scheinberg, MD, Katherine Calvo, MD, PhD, Yong Tang, Susan Soto, RN, Xingmin Feng, PhD, Ronan G. Desmond, MD, MRCP, FRCPath, Jay N. Lozier, M.D., Ph.D., Neal S. Young, MD, Cynthia E. Dunbar, MD

Blood (2011) 118 (21): 54.

https://doi.org/10.1182/blood.V118.21.54.54

Published: 2011

Journal Articles

Final Phase I/II Results of Rigosertib (ON 01910.Na) Hematological Effects in Patients with Myelodysplastic Syndrome and Correlation with Overall Survival,

Azra Raza, MD, Peter L. Greenberg, MD, Matthew J. Olnes, MD, PhD, Lewis R. Silverman, MD, Francois Wilhelm, MD, PhD.

Blood (2011) 118 (21): 3822.

https://doi.org/10.1182/blood.V118.21.3822.3822

Published: 2011

Journal Articles

Systemically Administered Hydrocortisone Exerts Differential Effects on B and T Lymphocytes and Natural Killer Cells in Healthy Donors

Matthew J. Olnes, MD, PhD, Angelique Biancotto, PhD, Ena Wang, M.D., Robert Reger, Shira Perl, MD, Howard Dickler, MD, J. Philip McCoy, PhD, Francesco Marincola, M.D., Richard Childs, MD, Neal S. Young, MD

Blood (2011) 118 (21): 2179.

https://doi.org/10.1182/blood.V118.21.2179.2179

Published: 2011

Journal Articles

JAK2 Inhibition with TG101348 Inhibits Monosomy 7 Myelodysplastic Syndromes (MDS) Bone Marrow Cells In Vitro: a Potential Targeted Therapy for Monosomy 7 MDS

Matthew J. Olnes, MD, PhD, Andrea Poon, BS, Zachary Tucker, BS, Neal S. Young, MD, Elaine M Sloand, MD

Blood (2010) 116 (21): 973.

https://doi.org/10.1182/blood.V116.21.973.973

Published: 2010

Journal Articles

Eltrombopag Can Stimulate Trilineage Hematopoiesis In Patients with Refractory Severe Aplastic Anemia

Matthew J. Olnes, MD, PhD, Yong Tang, MD, Susan Soto, RN, Elaine M Sloand, MD, Philip Scheinberg, MD, Neal S. Young, MD, Cynthia E. Dunbar, MD

Blood (2010) 116 (21): 4427.

https://doi.org/10.1182/blood.V116.21.4427.4427

Published: 2010

Journal Articles

Effects of Granulocyte Colony Stimulating Factor (G-CSF) On Monosomy 7 Aneuploidy and T Cell Subsets in Healthy Donors.

Matthew J. Olnes, MD, PhD, Susan Leitman, MD, Angelique Biancotto, PhD, J. Philip McCoy, Jr., PhD, Susan Miranda, BA, Zachary Tucker, BA, Loretta Pfannes, BS, Megan Furnari, Neal S Young, MD, Elaine M Sloand, MD

Blood (2009) 114 (22): 3147.

https://doi.org/10.1182/blood.V114.22.3147.3147

Published: 2009

Journal Articles

ON 01910.Na Suppresses Cyclin D1 Accumulation in trisomy 8 Myelodysplastic Syndromes Patients While Decreasing Bone Marrow CD34+ Blast Counts and Aneuploid Clone Size.

Elaine M Sloand, MD, Matthew J. Olnes, MD, PhD, Naomi Galili, PhD, Aarthi Shenoy, MD, Loretta Pfannes, Francois Wilhelm, MD, Ph.D, Barbara Weinstein, Phillip Scheinberg, MD, Jerome E. Groopman, MD, Azra Raza

Blood (2009) 114 (22): 120.

https://doi.org/10.1182/blood.V114.22.120.120

Published: 2009

Journal Articles

Alemtuzumab Treatment of Intermediate-1 (INT-1) Myelodysplasia Patients Is Associated with Sustained Improvement in Blood Counts and Cytogenetic Remissions.

Elaine M Sloand, MD, Matthew J. Olnes, MD, PhD, Barbara Weinstein, Phillip Scheinberg, MD, Neal S Young, MD

Blood (2009) 114 (22): 116.

https://doi.org/10.1182/blood.V114.22.116.116

Published: 2009

NARROW

Eltrombopag for Refractory Severe Aplastic Anemia: Dosing Regimens, Long-Term Follow-up, Clonal Evolution and Somatic Mutation Profiling

Persistent Elevation of Plasma Thrombopoietin Levels in Severe Aplastic Anemia, Even with Hematologic Recovery

Alemtuzumab Is Safe and Associated With High Response Rates In Selected Patients With Myelodysplastic Syndrome

Ultra-Low Dose IL-2 Safely Expands Regulatory T Cells and CD56 bright NK Cells in Healthy Volunteers: Towards Safer Stem Cell Donors?

Immunosuppressive Treatment for Patients with Myelodysplastic Syndromes: A Review of 358 Patients

Eltrombopag Can Stimulate Trilineage Hematopoiesis with Transfusion Independence in Patients with Refractory Severe Aplastic Anemia: Results From a Phase II Trial

Final Phase I/II Results of Rigosertib (ON 01910.Na) Hematological Effects in Patients with Myelodysplastic Syndrome and Correlation with Overall Survival,

Systemically Administered Hydrocortisone Exerts Differential Effects on B and T Lymphocytes and Natural Killer Cells in Healthy Donors

JAK2 Inhibition with TG101348 Inhibits Monosomy 7 Myelodysplastic Syndromes (MDS) Bone Marrow Cells In Vitro: a Potential Targeted Therapy for Monosomy 7 MDS

Eltrombopag Can Stimulate Trilineage Hematopoiesis In Patients with Refractory Severe Aplastic Anemia

Effects of Granulocyte Colony Stimulating Factor (G-CSF) On Monosomy 7 Aneuploidy and T Cell Subsets in Healthy Donors.

ON 01910.Na Suppresses Cyclin D1 Accumulation in trisomy 8 Myelodysplastic Syndromes Patients While Decreasing Bone Marrow CD34+ Blast Counts and Aneuploid Clone Size.

Alemtuzumab Treatment of Intermediate-1 (INT-1) Myelodysplasia Patients Is Associated with Sustained Improvement in Blood Counts and Cytogenetic Remissions.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only